Journal of Medicinal Chemistry p. 4244 - 4273 (2012)
Update date:2022-09-26
Topics: Lead Optimization Antimalarial Agents
Nagle, Advait
Wu, Tao
Kuhen, Kelli
Gagaring, Kerstin
Borboa, Rachel
Francek, Caroline
Chen, Zhong
Plouffe, David
Lin, Xuena
Caldwell, Christopher
Ek, Jared
Skolnik, Suzanne
Liu, Fenghua
Wang, Jianling
Chang, Jonathan
Li, Chun
Liu, Bo
Hollenbeck, Thomas
Tuntland, Tove
Isbell, John
Chuan, Tiffany
Alper, Philip B.
Fischli, Christoph
Brun, Reto
Lakshminarayana, Suresh B.
Rottmann, Matthias
Diagana, Thierry T.
Winzeler, Elizabeth A.
Glynne, Richard
Tully, David C.
Chatterjee, Arnab K.
On the basis of the initial success of optimization of a novel series of imidazolopiperazines, a second generation of compounds involving changes in the core piperazine ring was synthesized to improve antimalarial properties. These changes were carried out to further improve the potency and metabolic stability of the compounds by leveraging the outcome of a set of in vitro metabolic identification studies. The optimized 8,8-dimethyl imidazolopiperazine analogues exhibited improved potency, in vitro metabolic stability profile and, as a result, enhanced oral exposure in vivo in mice. The optimized compounds were found to be more efficacious than the current antimalarials in a malaria mouse model. They exhibit moderate oral exposure in rat pharmacokinetic studies to achieve sufficient multiples of the oral exposure at the efficacious dose in toxicology studies.
View MoreContact:+86-571-87010026
Address:202, Zhenhua Road,
Contact:+86-731-84427351
Address:154 JIANXIANG SOUTH ROAD
Wuxi Zuping Food Science And Technology Co.,LTD.
Contact:+86-510-87210822
Address:Guanlin town
Zhengzhou Minzhong Pharmaceutical Co.,ltd
Contact:0086-371-65797115
Address:15/F,Jiangshan Bldg, NO.126 Huanghe Road,Zhengzhou, China
Chengdu CSH Pharmaceutical Co.,ltd
Contact:+86-(28)-85321971
Address:Block B,New Hope Int. Tian Fu New District, Chengdu, Sichuan, China
Doi:10.1016/j.ejmech.2010.09.058
(2010)Doi:10.1246/cl.2010.1132
(2010)Doi:10.1155/2010/807059
(2010)Doi:10.1016/0031-9422(89)80360-7
(1989)Doi:10.1021/ic1020059
(2011)Doi:10.1039/c3tc31588f
(2013)